Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104030981A reveals mild condition synthesis for Ivacaftor intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN111153881A details a novel alumina-catalyzed route for flavoxate intermediates, offering high purity, reduced waste, and scalable manufacturing for global supply chains.
Patent CN108069845B reveals a one-step bromination/oxidation route. Offers cost reduction in API manufacturing and high-purity intermediates for global supply chains.
Patent CN1022629C details a robust synthesis for broad-spectrum cephalosporins. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel enzymatic method for high-purity L-tyrosine. Reduces impurities and simplifies supply chain for pharmaceutical intermediate manufacturing globally.
Patent CN1634810A details a mild CuI-amino acid catalytic system for alkyne-aryl coupling, offering significant cost reduction in API manufacturing and high-purity intermediates.
Novel refining method eliminates column chromatography for cisatracurium besilate ensuring high purity and scalable manufacturing for global supply chains.
Novel copper-catalyzed route for 9,10-phenanthraquinone compounds. Offers mild conditions, reduced toxicity, and scalable manufacturing for pharmaceutical and dye intermediates.
Patent CN110240604B reveals a green Cu/TEMPO catalytic route for pyridooxazole derivatives, offering high yields and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN103298795A details a novel oxalate salt crystallization process for Letrozole intermediates, eliminating regioisomers and enabling scalable API manufacturing.
Novel patent CN101671309B details a cost-effective EFCP synthesis avoiding Grignard reagents. This reliable pharmaceutical intermediate supplier offers scalable routes for voriconazole production.
Patent CN106146536B details a novel everolimus preparation method offering improved yield and supply chain stability for pharmaceutical manufacturing.
Novel Ir-catalyzed visible light method for polysubstituted cyclopropanes. Enhances yield, reduces by-products, ensures scalable API intermediate production.
Patent CN112851571A reveals a novel synthesis of water-soluble TEMPO derivatives offering superior catalytic activity, stability, and cost-effective manufacturing for fine chemicals.
Novel PdCl2-catalyzed route for pyrido[2,3-d]pyrimidine compounds offers superior yield and purity. Ideal for cost-effective API manufacturing and scalable supply chains.
Patent CN103524502A details a high-efficiency Tadalafil synthesis using D-tryptophan. Discover cost-effective manufacturing strategies and supply chain advantages for this ED API.
Novel synthesis of cyclopropyl allene derivatives using cyclopropylacetylene. Reduces cost and improves supply chain reliability for fine chemical intermediates.
Patent CN115124535A details Au(I)-catalyzed synthesis of fused indoles with high fluorescence. Offers cost-effective routes for electronic chemical manufacturing.
Patent CN103524440A details a safer, thiophosgene-free route for Lesinurad intermediates, offering cost reduction and scalable manufacturing for gout therapeutics.
Novel acid-catalyzed oxidation route for Dapagliflozin Impurity A. High purity reference standard synthesis for quality control. Cost-effective API intermediate manufacturing.